ERIN WALKER: Open Payments
NPI 1922322700 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$174 in 8 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $450 · 2025 $174
Food & beverage: $174
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 1 | $35 |
| PharmaEssentia USA Corporation | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ARRAY BIOPHARMA INC | 1 | $19 |
| TAIHO ONCOLOGY, INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $13 |
Products named: ACCRUFER, BESREMI, OJJAARA, BRAFTOVI, LONSURF, OPDIVO, MONOFERRIC.
Industry payments across TX — which companies pay providers there.
